These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1574649)

  • 1. Stimulation of Kupffer cell tumoricidal activity by liposomal muramyl dipeptides.
    Phillips NC
    Res Immunol; 1992 Feb; 143(2):205-10. PubMed ID: 1574649
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Kupffer cell tumoricidal activity by immunomodulators encapsulated in liposomes.
    Daemen T
    Res Immunol; 1992 Feb; 143(2):211-4. PubMed ID: 1574650
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide.
    Brodt P; Blore J; Phillips NC; Munzer JS; Rioux JD
    Cancer Immunol Immunother; 1989; 28(1):54-8. PubMed ID: 2909283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.
    Phillips NC; Tsao MS
    Cancer Immunol Immunother; 1991; 33(2):85-90. PubMed ID: 2036662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages, metastasis and immunity.
    Phillips NC
    Prog Clin Biol Res; 1990; 354A():257-70. PubMed ID: 2247491
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
    Phillips NC; Tsao MS
    Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.
    Stukart MJ; Rijnsent A; Roos E
    Cancer Res; 1987 Jul; 47(14):3880-5. PubMed ID: 3109735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance.
    Karpoff HM; Jarnagin W; Delman K; Fong Y
    Surgery; 2000 Aug; 128(2):213-8. PubMed ID: 10922994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocytic and tumoricidal heterogeneity of rat liver macrophage populations.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Sel Cancer Ther; 1989; 5(4):157-67. PubMed ID: 2623381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.
    Phillips NC; Chedid L
    Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in situ activation of cytotoxic properties in murine Kupffer cells by the systemic administration of whole Mycobacterium bovis organisms or muramyl tripeptide.
    Xu Z; Fidler IJ
    Cancer Immunol Immunother; 1984; 18(2):118-22. PubMed ID: 6391654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation.
    Phillips NC; Stewart-Phillips J; Wang P
    J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):185-93. PubMed ID: 8032541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Kupffer cell activity by muramyl dipeptide ameliorates normothermic liver ischemia/reperfusion in rats.
    Cursio R; Gugenheim J; Panaia-Ferrari P; Lasfar A; Tovey M; Chastanet S; Saint-Paul MC; Crenesse D; Mouiel J
    Transplant Proc; 1999 Aug; 31(5):2146-7. PubMed ID: 10455995
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate.
    McLaughlin CA; Schwartzman SM; Horner BL; Jones GH; Moffatt JG; Nestor JJ; Tegg D
    Science; 1980 Apr; 208(4442):415-6. PubMed ID: 7189295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
    Tandon P; Utsugi T; Sone S
    Cancer Res; 1986 Oct; 46(10):5039-44. PubMed ID: 3489519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
    van de Water B; van Berkel TJ; Kuiper J
    Mol Pharmacol; 1994 May; 45(5):971-7. PubMed ID: 8190111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.